SJ

Samantha Jérusalmy

Partner at Elaia Partners

Paris, Île-de-France

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Partner

    2014

    Elaia manages over €750m and invests in B2B tech-intensive & deep tech startups. Elaia diversified portfolio includes companies such as Mirakl, Criteo, Shift Technology, Ornikar, Vibe, IbanFirst, The Hotel Network, Zenchef, Aqemia, Doccla, Alice & Bob, Inato, etc. More on http://www.elaia.com

  • Investment Manager

    2011 - 2014

  • Analyst

    2008 - 2011

2024

  • Board Member

    2024

    Inato matches the right sites to the right clinical research study, globally.

  • Board Member

    2024

    ARMIS is the multilocale technology platform that automates local digital campaigns through creation, distribution and geolocalized optimization.

2024

  • Board Observer

    2024

    Doccla is a leader in multi-pathology remote monitoring across Europe. It is a trusted partner of 50% of NHS healthcare facilities in the UK and operates in nine other European countries. Doccla has already accumulated 4m daily patients and a NPS of over 70, indicating very high patient satisfaction.

2024

  • Board Member

    2024

    Adomik collects the advertising data from all your ad servers, SSPs, header partners to deliver insights that make your programmatic business thrive.

2022

  • Board Member

    2022

    LynxCare is an AI-powered Big Data platform enabling hospitals to mine their legacy data, to improve clinical efficiency and higher the quality of care.

  • Board Member

    2021

    Digital therapeutics pioneer specializing in the development of mobile medical application games used as monitoring and rehabilitation tools for chronic diseases.

2020

  • Board Member

    2020

    inHEART is committed to delivering the world’s most sophisticated, AI-enabled, digital twin of the heart to advance the care of patients living with cardiac disease

2019

  • Board Member

    2019

    Sim&Cure is a digital start-up focused on improving neurovascular treatments of cerebral aneurysm with a proprietary software suite (Class IIa medical device with CE mark and FDA 510k cleared) that has already been used to treat more than 10,000 patients in 500+ hospitals.

  • Board Member

    2018

    SaaS-based Location Intelligence solution that helps professionals from the retail, real estate, and FMCG industries make informed decisions about their business strategies. Mytraffic acquires Geoblink. They are joining forces to help businesses globally, build better strategies with traffic analytics and geospatial intelligence.